For patients with suspected obstructive sleep apnea, a previous sleep study may not be required to indicate the need for continuous positive airway pressure treatment.
The Pittsburgh Sleep Quality Index is a valid tool to use for gender comparisons of perceived sleep quality.
Increased positive airway pressure therapy time for patients with obstructive sleep apnea yields better results.
Common comorbidities in OSA such as cardiovascular disease and metabolic abnormalities, may confer a higher risk for the development of mental and cognitive impairment in patients with OSA compared with the general population.
Considerable differences exist between men and women with respect to the diagnosis of obstructive sleep apnea, with female gender shown to be an independent, significant predictor of prevalent cardiovascular disease.
Treatment with noninvasive ventilation and continuous positive airway pressure provided similar improvements in pulmonary hypertension and left ventricular diastolic dysfunction in obesity hypoventilation syndrome and concomitant severe obstructive sleep apnea.
Even after long-term continuous positive airway pressure (CPAP) use, intensive telemedicine support can be used to help optimize CPAP adherence in patients with obstructive sleep apnea.
Increased compliance with continuous positive airway pressure therapy may reduce the risk for the development of diabetic retinopathy in patients with type 2 diabetes who have obstructive sleep apnea.
The severity of obstructive sleep apnea is independently associated with subclinical systemic atherosclerosis, which highlights its potential as a predictive factor for cardiovascular disease.
Patients with sleep apnea are 4 more likely to be prescribed home oxygen after hospital discharge than those without sleep apnea.
